MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4103/jcrt.jcrt_404_20

Медицинская библиотека · Journal of cancer research and therapeutics · 2022

Definitive radiation therapy with dose escalation is beneficial for patients with squamous cell cancer of the esophagus.

Ghosh-Laskar Sarbani, Mummudi Naveen, Kumar Saurabha, Chandre Mukesh, Mishra Shagun, Tibdewal Anil, Agarwal Jai Praklash, Patil Vijay, Noronha Vanita, Prabash Kumar, Patil Prachi, Jiwnani Sabita, Karimundackal George, Pramesh C S

Клиническое исследованиеСтатьяПеревод пока не подготовлен

Аннотация

OBJECTIVE

We report the long term follow-up, toxicity, and outcomes of patients with localized squamous cell carcinoma of the esophagus(ESCC) who underwent definitive chemo-radiotherapy(dCRT) at our institute.

MATERIALS AND

METHODS

Patients diagnosed with carcinoma post cricoid, upper cervical and thoracic oesophagus and treated with dCRT between January 2000 and March 2012 were retrospectively analyzed. Radiotherapy was delivered in two phases to a maximum dose of 63Gy in daily fractions of 1.8Gy using conventional or conformal techniques. OS and PFS were defined from date of registration and were calculated by Kaplan-Meier method with comparisons between different subgroups performed using log-rank test. All data were analysed using SPSS Version 22.

RESULTS

Three hundred and fourteen patients with ESCC treated with dCRT were included in this analysis. Median age at presentation was 56 years and median KPS at presentation was 70. Two-third of patients were treated with conformal technique. Median dose of radiation delivered was 60Gy(range 30.6Gy-70Gy). Neoadjuvant chemotherapy was administered in about 35% patients and 57% patients received concurrent chemotherapy. About 10% patients required hospitalization during treatment due to complications and 7 patients did not complete treatment. Grade 1/2 dermatitis and mucositis was seen in 77% and 71% patients respectively. Complete response at first follow up was observed in 56% of patients. At a median follow up of 56 months, 77 patients were alive with controlled disease. The 1- and 3-yr OS were 80% and 62% respectively. Median PFS was 28 months; 1- and 3-yr PFS were 66% and 46% respectively. A higher RT dose was found to be a significant predictor for OS and PFS on both uni- and multivariate analysis.

CONCLUSION

Our study highlights that the delivery of higher RT doses (≥63Gy) is feasible in this patient group and that a higher RT dose was associated with significantly better PFS and OS.

Для цитирования: Ghosh-Laskar Sarbani, Mummudi Naveen, Kumar Saurabha, Chandre Mukesh, Mishra Shagun, Tibdewal Anil, Agarwal Jai Praklash, Patil Vijay, Noronha Vanita, Prabash Kumar, Patil Prachi, Jiwnani Sabita, Karimundackal George, Pramesh C S. Definitive radiation therapy with dose escalation is beneficial for patients with squamous cell cancer of the esophagus.. Journal of cancer research and therapeutics. 2022. DOI: 10.4103/jcrt.jcrt_404_20.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.